Sri Lanka has officially called for a stronger, more integrated partnership with India in the pharmaceutical and healthcare sectors. The initiative aims to enhance regional health security, stabilize supply chains for essential medicines, and leverage cutting-edge digital health solutions.
Key Highlights
- Sri Lanka invites greater Indian investment into domestic pharmaceutical manufacturing and medical infrastructure.
- Emphasis placed on establishing strategic joint ventures to reduce import dependency for vital drugs.
- Collaboration extends to digital health technologies, capacity building, and knowledge exchange between healthcare professionals.
Speaking on the strategic value of bilateral cooperation, Sri Lankan officials highlighted India’s position as a global leader in pharmaceuticals and healthcare innovation. The proposed collaboration focuses on establishing a robust framework for local drug manufacturing, ensuring steady access to life-saving medications, and modernizing healthcare infrastructure across the island nation.
In addition to trade and manufacturing, the dialogue emphasizes mutual cooperation in digital health platforms and regulatory alignment. By harnessing India’s technological expertise and technical know-how, Sri Lanka aims to build a resilient healthcare ecosystem capable of addressing evolving public health challenges in South Asia.